Active Ingredient: APREMILAST
Proprietary Name: OTEZLA XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 75MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210745
Product Number: 001
Approval Date: Aug 29, 2025
Applicant Holder Full Name: AMGEN INC
Marketing Status:
Prescription
Patent and Exclusivity Information